Utama › Kanser Darah › Tennessee › Nashville
Kajian klinikal Kanser Darah di Nashville, TN
13 kajian untuk Kanser Darah sedang mencari peserta di lokasi dalam dan sekitar Nashville (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Mengambil pesertaFasa 3
- Vanderbilt Health One Hundred Oaks Diagnostic ( Site 0060), Nashville
- Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0015), Nashville
A Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies
Mengambil pesertaFasa 1
- Sarah Cannon Cancer Institute, Nashville
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Mengambil pesertaFasa 3
- Quetzal Site 12, Nashville
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Mengambil pesertaFasa 1
- Scri Oncology Partners, Nashville
- Vanderbilt Medical Center, Nashville
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Mengambil pesertaFasa 3
- Tennessee Oncology, Nashville
- TriStar Centennial Medical Center, Nashville
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Mengambil pesertaFasa 1
- Vanderbilt University Medical Center, Nashville
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute - Oncology Partners, Nashville
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Mengambil pesertaFasa 2
- Vanderbilt University, Ingram Cancer Center, Nashville
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- Vanderbilt University, Nashville
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
Mengambil pesertaFasa 3
- The Children's Hospital at TriStar Centennial, Nashville
- Vanderbilt University/Ingram Cancer Center, Nashville
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Mengambil pesertaFasa 1
- TriStar Bone Marrow Transplant, Nashville
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
Mengambil pesertaFasa 1/2
- SCRI Oncology Partners, Nashville
Study of VIP943 in Subjects With Advanced CD123+ Hematologic Malignancies
Mengambil pesertaFasa 1
- TriStar Bone Marrow Transplant, Nashville
Kajian Kanser Darah di bandar lain
- Houston, TX46 kajian
- New York City, NY26 kajian
- Boston, MA25 kajian
- Washington, DC19 kajian
- Seattle, WA18 kajian
- Baltimore, MD18 kajian
- Los Angeles, CA17 kajian
- Durham, NC16 kajian
- Chicago, IL15 kajian
- Philadelphia, PA14 kajian
- Columbus, OH13 kajian
- Edison, NJ13 kajian
Kajian lain di Nashville
- Kanser Paru-paru Bukan Sel Kecil97 kajian
- Kanser Payudara81 kajian
- Kanser Metastatik70 kajian
- Kanser Kolorektal69 kajian
- Kanser (semua jenis)65 kajian
- Kanser Ovari49 kajian
- Kanser Prostat43 kajian
- Kanser Paru-paru40 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher39 kajian
- Kanser Pankreas39 kajian
- Kanser Endometrium38 kajian
- Melanoma33 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.